Delivery Order SPE2DB20D2014-SPE2DB25FD16J
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,047.27 to AmerisourceBergen Drug Corp for Alphagan P 0.15% eye drops (5ml) on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside order represents a firm fixed price delivery under AmerisourceBergen's broader pharmaceutical supply contract. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Alphagan P 0.1% ophthalmic drops in 15ml quantities, with a ceiling value of $1,034.90. This competitively awarded, non-set-aside firm fixed price delivery order is scheduled for completion by July 28, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,518.75 to AmerisourceBergen Drug Corp for the supply of Alphagan P 0.1% ophthalmic drops (15 milliliter units) under a firm fixed-price arrangement. This non-set-aside delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical distribution portfolio. The product will be delivered to the Place of Performance...
- The Defense Logistics Agency awarded a $6,451.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Alphagan P 0.15% ophthalmic drops (10ml) on May 15, 2025, with an ultimate completion date of May 16, 2025. This non-set-aside contract was competitively awarded and performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ALPHAGAN P 0.15% eye drops in 10ml bottles. The contract has a ceiling value of $7,471.82 and a completion date of September 3, 2024. It is a firm fixed-price contract, and there is no set-aside designation. Amerisourcebergen is the prime contractor, and the contract is part of a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ALPHAGAN P 0.15% eye drops. The contract has a ceiling value of $1,349.48 and a period of performance through March 31, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alphagan P 0.1% eye drops, a prescription medication used to treat glaucoma. The contract has a firm fixed price of $5,040.91 and a completion date of November 25, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,083.93 Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The order is for the delivery of ALPHAGAN P 0.15% EYE DROPS 5ML, with a completion date of April 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $11,570.46 firm fixed-price contract is for the supply of ALPHAGAN P 0.15% eye drops in 5 ml bottles. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999, for providing a wide range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for a supply of Alphagan 0.15% ophthalmic solution (5mL, 1 unit) with a ceiling value of $1,368.30. This firm fixed-price delivery order, which must be completed by October 21, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD16JDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Alphagan P 0.15% eye drops in 10ml quantities, with a ceiling value of $3,772.53 and a completion date of September 30, 2025. This competitive, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through its comprehensive Medical Supply Chain vehicle. AmerisourceBergen's DLA Troop Support Medical IDC functions as a global pharmaceutical support vehicle enabling the delivery of a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order for ophthalmic medication represents a routine procurement from the company's extensive portfolio of pharmaceutical products supplied through competitive federal contracts. The DLA's strategic approach to pharmaceutical procurement through such prime vendor vehicles allows the agency to efficiently meet medical supply requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/29/25 |